[{"data":1,"prerenderedAt":68},["ShallowReactive",2],{"q-nurse-108-2-basic-medicine-063":3},{"subject":4,"subjectSlug":5,"subjectFullName":6,"question":7,"related":37,"lastmod":67},"基礎醫學","basic-medicine","基礎醫學(包括解剖學、生理學、病理學、藥理學、微生物學與免疫學)",{"id":8,"webId":9,"year":10,"session":11,"subject":4,"number":12,"stem":13,"options":14,"answer":19,"answerNote":20,"images":21,"explanation":22,"explanationDeep":23,"topics":24,"freq":27},"nurse-108-2-基礎醫學-063","nurse-108-2-basic-medicine-063",108,2,63,"關於 corticosteroid 的臨床用途，下列何者錯誤？",{"A":15,"B":16,"C":17,"D":18},"治療庫欣氏症候群（Cushing’s syndrome）","治療類風濕性關節炎（rheumatoid arthritis）","預防器官移植所造成的排斥現象","加速胎兒肺臟的成熟","A",null,[],"本題考點為 corticosteroid 的臨床適應症與庫欣氏症候群的病因。依內分泌病生理，庫欣氏症候群本身即因糖皮質素過量（內源分泌過多或外源用藥）所致，再給予類固醇只會加重病情，故『治療庫欣氏症候群』為錯誤用途，選 A。（B）類固醇具強效抗發炎與免疫抑制作用，是類風濕性關節炎急性期常用藥，敘述正確。（C）抑制 T 細胞活化與細胞激素生成，用於器官移植抗排斥，正確。（D）產前給母體類固醇（如 betamethasone）可促進第二型肺泡細胞分泌表面張力素、加速胎兒肺成熟以防新生兒呼吸窘迫，正確。","糖皮質素作用面極廣：抑制磷脂酶 A2、降低前列腺素與白三烯素生成而抗發炎，並抑制免疫細胞。庫欣氏症候群的表徵（月亮臉、水牛肩、皮膚紫紋、高血糖）正是類固醇過量的鏡像，故它是類固醇的『副作用清單』而非治療對象。記憶法：類固醇能治『發炎、免疫、排斥、促胎肺』，唯獨不能治因它自己過量而生的庫欣氏症候群——病因與療效方向相反即為破題點。",[25,28,30,33,35],{"term":26,"count":27},"庫欣氏症候群",3,{"term":29,"count":11},"表面張力素",{"term":31,"count":32},"糖皮質素",1,{"term":34,"count":32},"抗發炎免疫抑制",{"term":36,"count":32},"胎兒肺成熟",[38,42,47,52,57,62],{"webId":39,"stem":40,"number":41,"year":10,"session":11},"nurse-108-2-basic-medicine-064","服用下列何種藥物，須注意病人的視力是否有異常？",64,{"webId":43,"stem":44,"number":45,"year":46,"session":32},"nurse-109-1-basic-medicine-080","下列何種細菌因缺乏細胞壁，因此無法使用青黴素來治療？",80,109,{"webId":48,"stem":49,"number":50,"year":51,"session":32},"nurse-110-1-basic-medicine-014","依照大腸（large intestine）前後排列之順序，下列何者在最前端？",14,110,{"webId":53,"stem":54,"number":55,"year":56,"session":32},"nurse-111-1-basic-medicine-052","下列藥物中，何者不適用於治療生長激素分泌過多而產生的肢端肥大症？",52,111,{"webId":58,"stem":59,"number":60,"year":61,"session":27},"nurse-112-3-basic-medicine-026","下列何者不是動脈粥狀硬化（arteriosclerosis）的高危險因子？",26,112,{"webId":63,"stem":64,"number":65,"year":66,"session":32},"nurse-114-1-basic-medicine-020","下列何者源自骨髓細胞，而後遷移至中樞神經系統內成熟？",20,114,"2026-09-04",1788510705353]